Mesenchymal Stromal Cells from the Maternal Segment of Human Umbilical Cord is Ideal for Bone Regeneration in Allogenic Setting
10.1007/s13770-017-0086-6
- Author:
Jezamine LIM
1
;
Zainul Rashid Mohamad RAZI
;
Jia Xian LAW
;
Azmawati Mohammed NAWI
;
Ruszymah Binti Haji IDRUS
;
Tan Geok CHIN
;
Muaatamarulain MUSTANGIN
;
Min Hwei NG
Author Information
1. Tissue Engineering Centre, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000 Kuala Lumpur, Malaysia. angelaster3@gmail.com
- Publication Type:Original Article
- Keywords:
Bone;
Mesenchymal stromal cells;
Tissue engineering;
Wharton's jelly;
Allogeneic
- MeSH:
Adult;
Animals;
Bone Regeneration;
Cell Transplantation;
Cesarean Section;
Female;
Fibrin;
Humans;
Infant;
Inflammation;
Mesenchymal Stromal Cells;
Mice;
Osteogenesis;
Pregnancy;
Tissue Donors;
Tissue Engineering;
Transplants;
Umbilical Cord;
Wharton Jelly
- From:
Tissue Engineering and Regenerative Medicine
2018;15(1):75-87
- CountryRepublic of Korea
- Language:English
-
Abstract:
Umbilical cord (UC) is a discarded product from the operating theatre and a ready source of mesenchymal stromal cells (MSCs). MSCs from UC express both embryonic and adult mesenchymal stem cell markers and are known to be hypoimmunogenic and non-tumorigenic and thus suitable for allogeneic cell transplantation. Our study aimed to determine the degree of immunotolerance and bone-forming capacity of osteodifferentiated human Wharton's jelly-derived mesenchymal stromal cells (hWJ-MSCs) from different segments of UC in an allogenic setting. UCs were obtained from healthy donors delivering a full-term infant by elective Caesarean section. hWJ-MSCs were isolated from 3 cm length segment from the maternal and foetal ends of UCs. Three-dimensional fibrin constructs were formed and implanted intramuscularly into immunocompetent mice. The mice were implanted with 1) fibrin construct with maternal hWJ-MSCs, 2) fibrin construct with foetal hWJ-MSCs, or 3) fibrin without cells; the control group received sham surgery. After 1 month, the lymphoid organs were analysed to determine the degree of immune rejection and bone constructs were analysed to determine the amount of bone formed. A pronounced immune reaction was noted in the fibrin group. The maternal segment constructs demonstrated greater osteogenesis than the foetal segment constructs. Both maternal and foetal segment constructs caused minimal immune reaction and thus appear to be safe for allogeneic bone transplant. The suppression of inflammation may be a result of increased anti-inflammatory cytokine production mediated by the hWJ-MSC. In summary, this study demonstrates the feasibility of using bone constructs derived from hWJ-MSCs in an allogenic setting.
